Coverage
Filings
| Filing | Date |
|---|---|
| ORION CORPORATION SHARE REPURCHASE 21.01 | 21 Jan 2003 |
| ORION CORPORATION SHARE REPURCHASE 20.01 | 20 Jan 2003 |
| ORION CORPORATION SHARE REPURCHASE 17.01 | 17 Jan 2003 |
| ORION CORPORATION SHARE REPURCHASE 16.01 | 16 Jan 2003 |
| ORION CORPORATION SHARE REPURCHASE 15.01 | 15 Jan 2003 |
| ORION CORPORATION SHARE REPURCHASE 14.01 | 14 Jan 2003 |
| ORION CORPORATION SHARE REPURCHASE 13.01 | 13 Jan 2003 |
| ORION CORPORATION SHARE REPURCHASE 09.01 | 10 Jan 2003 |
Orion's collaboration partner Bayer announced U.S. FDA approval for darolutamide, an androgen receptor inhibitor (ARi), for metastatic hormone-sensitive prostate cancer (mHSPC).
| ORION CORPORATION SHARE REPURCHASE 10.01 | 10 Jan 2003 |
| ORION CORPORATION SHARE REPURCHASE 09.01 | 9 Jan 2003 |
| ORION CORPORATION SHARE REPURCHASE 08.01 | 8 Jan 2003 |
| ORION CORPORATION SHARE REPURCHASE 07.01 | 7 Jan 2003 |